You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Features & Benefits

READY-TO-GO
Allograft that may be stored at ambient temperature, does not require pre-hydration, and remains shelf stable for 5 years.

WORKFLOW INTEGRATION
DODTM Allografts, in many cases, can be inserted directly in line with the surgeon’s existing workflow.

LESS EXPENSIVE
The size of DODTM Allograft allows surgeons to build up only what is necessary for each individual patient, preventing discarded tissue and potentially reducing costs relative to traditional soft tissue augmentation grafts6.

OPEN DERMAL MATRIX™ TECHNOLOGY
DODTM Allografts feature OPEN DERMAL MATRIXTM Technology which has been shown in pre-clinical animal models to integrate better than traditional dermal allografts.2 Note: Results in animal model may not directly correlate with clinical use.

BROAD COMPRESSION
PERMACORD® Suture with DODTM Allograft provides a broader compression area than PERMACORD® Suture alone, which may correspond with more tendon to bone contact.5
Available in US only. DERMIS ON DEMANDTM is promoted by DePuy Synthes, distributed by Parametrics Medical, and processed by an accredited tissue bank. The third-party trademarks herein are the trademarks of their respective owners.
Product Resources
Product Resources
Simulated use testing demonstrated that DODTM could be incorporated in to a standard RCR technique with an average time of 17.7 seconds(n=24).4
Allograft Dimensions: | Allograft Dimensions: | |||||||
---|---|---|---|---|---|---|---|---|
15 mm long x 4.5 mm wide x 3 mm thick | ||||||||
References
- ADAPTIV Test Report 103648915 Rev 2
- ADAPTIV Test Report 103579435 Rev 2
- ADAPTIV Test Report 103592792 Rev 2 and 190807 HSS lab notes.pdf
- ADAPTIV Test Report 103662627 Rev 1
- ADAPTIV Test Report 103649074 Rev 1
- Source: Medtech360 US Orthopedic Extremity Devices, Decision Resources Group, May 2016
Intended Use
DERMIS ON DEMAND™ Allografts are an HCT/P (human cells, tissues or cellular, or tissue based product) regulated solely under Section 361 of the Public Health Service (PHS) Act and 21 C.F.R. Part 1271. It is an allogeneic, processed acellular dermis intended for homologous use only, including the supplemental support, protection, reinforcement or covering of soft tissue.
139037-200611 DSUS
© DePuy Synthes 2020. All Rights Reserved. This site is published by the DePuy Synthes Companies, which are solely responsible for its content. This site is governed solely by applicable U.S. laws and governmental regulations. This site is for visitors from the United States. The third party trademarks used herein are the trademarks of their respective owners.